Skip to main content

ESTUDIO DE LA FUNCION MITOCONDRIAL, LA AUTOFAGIA Y LA MITOFAGIA EN LA DIABETES TIPO 2: RELACION CON LAS COMPLICACIONES CARDIOVASCULARES E IMPLICACIONES CLINICAS

PI19/00838

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA EL FOMENTO DE LA INV. SANITARIA Y BIOMEDICA DE LA COMUNIDAD VALENCIANA (FISABIO)
Execution centre HOSPITAL DOCTOR PESET

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets

  • Apostolova, Nadezda
  • Vezza, Teresa
  • Muntané, Jordi
  • Rocha, Milagros
  • Victor, Víctor M.
Significance: Type 2 diabetes mellitus, which is related to oxidative stress and mitochondrial dysfunction, is one of the most prevalent diseases in the world. In the past decade, alterations in autophagy have been shown to play a fundamental role in the development and control of type 2 diabetes. Further, mitophagy has been recognized as a key player in eliminating dysfunctional mitochondria in this disease. Recent Advances: Recently, much progress has been made in understanding the molecular events associated with oxidative stress, mitochondrial dysfunction, and alterations in autophagy and mitophagy in type 2 diabetes. Critical Issues: Despite increasing evidence of a relationship between mitochondrial dysfunction, oxidative stress, and alterations of autophagy and mitophagy and their role in the pathophysiolology of type 2 diabetes, effective therapeutic strategies to combat the disease through targeting mitochondria, autophagy, and mitophagy are yet to be implemented. Future Directions: This review provides a wide perspective of the existing literature concerning the complicated interplay between autophagy, mitophagy, and mitochondrial dysfunction in type 2 diabetes. Further, potential therapeutic targets based on these molecular mechanisms are explored. Antioxid. Redox Signal. 39, 278–320., This research was supported by the European Regional Development Fund (ERDF “A way to build Europe”); FISABIO (Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, grants UGP15-220 and UGP-21-236); Generalitat Valenciana (grants PROMETEO/2019/027 and AICO/2021/017); and Spanish Ministry of Science and Innovation (grants CIBERehd CB06/04/0071, PI22/00424, PI22/1009, PI19/0437, and PI19/00838 from Carlos III Health Institute, and grant PID2021-127945OB-I00 funded by MCIN/AEI/10.13.039/501100011033/and by FEDER)., Peer reviewed